breast cancer

FDA approves breakthrough breast cancer drug

  • Mon, 06/11/2012 - 2:57pm

In an unprecedented breakthrough in breast cancer research, the FDA approved a new drug that should improve on the treatment of one of the most deadly forms of breast cancer to date, HER2-positive.

Study shows lingering side effects with breast cancer treatment

  • Mon, 05/07/2012 - 3:13pm

A University of Pennsylvania research study revealed that 60 percent of breast cancer patients suffered at least one side effect up to six years after completing treatment and 30 percent experience